Press Room

More than 100 organizations representing millions of patients with serious health conditions and health care professionals sent a letter to Congress expressing their strong support for the Clinical Trial Modernization Act. Introduced in the House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-FL), the bipartisan legislation would help remove cost and geographic barriers to patient participation in clinical trials.

BIRMINGHAM, Ala.

El Proyecto de Ley Int. #1369-2025 requerirá que todos los empleadores privados con cinco o más empleados otorguen hasta cinco horas anuales de tiempo libre pagado para la atención médica preventiva, incluidos los exámenes recomendados por un médico.

 A new ACS CAN study released in the Journal of the American Medical Association (JAMA) finds many patients aren’t made aware of the importance of pharmacogenomic (PGx) testing. A form of biomarker testing, PGx testing examines how variations in a patient’s inherited genes may impact how they respond to different drugs and can improve the effectiveness of treatment and reduce the risk of adverse drug reactions.

Baton Rouge, LA. – Aug 12, 2025 – The American Cancer Society Cancer Action Network (ACS CAN) has placed two new billboards in Baton Rouge to catch Congress’s attention ahead of crucial votes coming up in Washington, D.C.

CHATTANOOGA, Tenn. – The American Cancer Society Cancer Action Network (ACS CAN) has placed five new billboards in the Chattanooga area to catch Congress’s attention ahead of crucial votes coming up in Washington, D.C.

Today, the U.S. Senate Committee on Appropriations considered and approved its draft FY26 appropriations bill that includes increases for the National Institutes of Health (NIH) and increases for federal cancer research funding at the National Cancer Institute (NCI).

BIRMINGHAM, Ala. – July 29, 2025 – The American Cancer Society Cancer Action Network (ACS CAN) has placed two new billboards in Alabama to catch Congress’s attention ahead of crucial votes coming up in Washington, D.C.

Today, the U.S. Senate voted to confirm Susan Monarez, PhD, as the next Director of the Centers for Disease Control and Prevention (CDC).

La Sociedad Americana Contra el Cáncer (ACS) y su afiliada de defensa, la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) anunciaron hoy a Shane Jacobson como su director ejecutivo, con vigencia a partir del 12 de agosto de 2025